Connor, Clark & Lunn Investment Management Ltd. Codexis, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$4.26 - $6.84 $80,548 - $129,330	18,908 New	18,908 $88,000
Q1 2022 May 12, 2022	SELL	$16.97 - $31.93 $174,451 - $328,240	-10,280 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$25.61 - $41.78 $118,420 - $193,190	-4,624 Reduced 31.03%	10,280 $321,000
Q3 2021 Nov 12, 2021	BUY	$19.65 - $27.99 $292,863 - $417,162	14,904 New	14,904 $347,000

Others Institutions Holding CDXS

# of Institutions

125

Shares Held

59.9M

Call Options Held

25.9K

Put Options Held

20.1K

Opaleye Management Inc. Boston, MA

8.77M
Shares

$34.5 Million
4.93% of portfolio
Casdin Capital, LLC New York, NY

8.1M
Shares

$31.8 Million
1.94% of portfolio
Black Rock Inc. New York, NY

6.79M
Shares

$26.7 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.15M
Shares

$16.3 Million
0.0% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

2.97M
Shares

$11.7 Million
0.54% of portfolio

View Full List

About CODEXIS, INC.

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $257M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

More about CDXS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account